.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Mallinckrodt
Fish and Richardson
QuintilesIMS
US Department of Justice
Cipla
Farmers Insurance
Federal Trade Commission
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,169,920

« Back to Dashboard

Which drugs does patent 6,169,920 protect, and when does it expire?


Patent 6,169,920 protects IONSYS and is included in one NDA.

This patent has ten patent family members in eleven countries.

Summary for Patent: 6,169,920

Title: Iontophoretic drug delivery apparatus
Abstract:An iontophoretic delivery device (10) is provided. Device (10) has an electronic circuit (32) having electronic components such as batteries (30) mounted thereon. Device (10) also includes a pair of electrode assemblies (18, 19). The electronic circuit (32) is electrically connected to the electrode assemblies (18, 19) using an electrically conductive adhesive (34). The adhesive can also be used to electrically connect two or more electronic components within circuit (32) or to connect an electronic component to the electronic circuit (32). In one practice of the invention, the electrically conductive adhesive (44) functions as an electrode and electrically connects the circuit (32) to an agent-containing reservoir (24, 25). In a further practice of the invention, the electrically conductive adhesive (93) functions as an agent reservoir and contains the agent to be iontophoretically delivered.
Inventor(s): Haak; Ronald P. (San Jose, CA), Meyers; Robert M. (Stanford, CA), Landrau; Felix A. (San Jose, CA), Sanders; Harold F. (La Jolla, CA), Kleiner; Lothar W. (Los Altos, CA), Gyory; J. Richard (San Jose, CA)
Assignee: Alza Corporation (Mountain View, CA)
Application Number:08/320,387
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
The Medicines CoIONSYSfentanyl hydrochlorideSYSTEM;IONTOPHORESIS, TRANSDERMAL021338-001May 22, 2006RXYesYes► Subscribe► SubscribeYMETHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 6,169,920

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,317,629 Iontophoretic drug delivery apparatus► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,169,920

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia4399193► Subscribe
Canada2134351► Subscribe
Germany69314634► Subscribe
Denmark0643600► Subscribe
European Patent Office0643600► Subscribe
Austria159179► Subscribe
Spain2108282► Subscribe
Greece3025670► Subscribe
JapanH07507465► Subscribe
World Intellectual Property Organization (WIPO)9324178► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Johnson and Johnson
Chubb
Chinese Patent Office
US Army
Cipla
Federal Trade Commission
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot